AME Company for Medical Supplies posted a net profit of SAR 28 million in H1 2025, compared to SAR 26.5 million in H1 2024.
Item | H1 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 133.46 | 161.48 | 21.0 % |
Gross Income | 58.18 | 70.25 | 20.7 % |
Operating Income | 27.42 | 30.38 | 10.8 % |
Net Income | 26.59 | 27.91 | 4.9 % |
Average Shares | 7.00 | 7.00 | - |
Earnings Per Share before unusual items (Riyal) | 3.80 | 3.99 | 4.9 % |
EPS (Riyal) | 3.80 | 3.99 | 4.9 % |
Item | H2 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 114.53 | 161.48 | 41.0 % |
Gross Income | 43.61 | 70.25 | 61.1 % |
Operating Income | 17.38 | 30.38 | 74.8 % |
Net Income | 18.45 | 27.91 | 51.3 % |
Average Shares | 7.00 | 7.00 | - |
Earnings Per Share before unusual items (Riyal) | 2.64 | 3.99 | 51.3 % |
EPS (Riyal) | 2.64 | 3.99 | 51.3 % |
The profit rise was driven by revenue increase, mainly due to higher sales of medical equipment and supplies by SAR 28 million. The company said this reflected an expanded market share, stronger demand, and enhanced sales coverage through larger marketing and sales teams.
Compared to H2 2024, AME’s profit jumped 48.4% from SAR 18.81 million.
Shareholders’ equity, no minority interests, stood at SAR 171.99 million as of June 30, compared to SAR 139.76 million in the same period last year
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: